In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Instituto Terapeutico Delta Ltda.

www.labdelta.com.br

Latest From Instituto Terapeutico Delta Ltda.

Deal Of The Week: Will Heated Competition To Buy Out Ache Laboratorios Muddy The Brazilian Waters?

Pfizer, Novartis and Abbott reportedly are battling to buy out family-owned Ache, Brazil’s leader in prescription drug sales.

BioPharmaceutical Brazil

Deals Of The Week: Will Heated Competition To Buy Out Ache Laboratorios Muddy The Brazilian Waters?

Pfizer, Novartis and Abbott reportedly are battling to buy out family-owned Ache, Brazil’s leader in prescription drug sales. Plus deals involving AstraZeneca and AlphaCore, Pfizer and Bind Therapeutics and Merck and Ra Pharma.

BioPharmaceutical United States

Pharmaceutical/Biotechnology Deal Statistics Quarterly, Q4 2011

Biopharmaceutical company financings more than doubled to $2.7 billion from Q3. There were 23 acquisitions bringing in a total of $17.7 billion. And in alliances there was a focus on biosimilars, oncology and neurology deals, and unique partnerships with clear paths to exits.

BioPharmaceutical Deals

Pharmaceutical/Biotechnology Deal Statistics Quarterly, Q2 2010

Highlights from the Q2 2010 review of pharmaceutical and biotechnology dealmaking: Biopharma companies raised a total of $3.4bn through 96 financings. Twenty-one acquisitions together reached $20.2bn, thanks to five deals each exceeding $3 billion - in aggregate accounting for 91% of the M&A total. The alliance volume was up to 115 transactions for a total of $2.8 billion in pre-commercialization money, with seven deals surpassing the $100 million mark.
BioPharmaceutical
See All

Company Information

  • Industry
  • Pharmaceuticals
    • OTC, Consumer
  • Therapeutic Areas
  • Dermatology
  • Alias(es)
  • Institute Therapeutic Delta Ltda.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • South America
      • Brazil
  • Parent & Subsidiaries
  • Instituto Terapeutico Delta Ltda.
  • Senior Management
  • Contact Info
  • Instituto Terapeutico Delta Ltda.
    Phone: (55) 19 3801 8900
    Road of Capouilla 129
    Industrial Dist
    Indaiatuba,
    Brazil
Advertisement
Advertisement
UsernamePublicRestriction

Register